SNY Jan 2025 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:58PM EDT. Market open.
Loading interactive chart…
- Zacks
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Sanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with inadequately controlled CRSwNP, if approved by the FDA.
- GuruFocus.com
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
Comprehensive Analysis of Fulcrum Therapeutics' Financial Performance and Future Outlook
- Fortune
France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive
France usually receives among the highest inward FDI in Europe, but even so $16 billion is a lot to announce on one day.
© 2024 Yahoo. All rights reserved.